Tyra Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	876	596	321	581	-	-
Market Cap Growth	26.31%	85.96%	-44.76%	-	-	-
Enterprise Value	499	398	71	279	-15	4
PE Ratio	-	-8.63	-5.80	-22.08	-	-
PB Ratio	2.25	2.92	1.24	1.92	-	-
P/FCF Ratio	-13.63	-11.71	-6.31	-23.81	-	-
P/OCF Ratio	-13.82	-11.89	-6.38	-24.45	-	-
EV/EBITDA Ratio	-6.45	-5.79	-1.29	-10.68	1.65	-1.10
EV/EBIT Ratio	-6.42	-5.76	-1.29	-10.62	1.64	-1.10
EV/FCF Ratio	-7.67	-7.83	-1.40	-11.45	1.90	-1.69
Debt / Equity Ratio	0.02	0.03	0.01	0.00	-0.01	-0.97
Debt / EBITDA Ratio	-0.09	-0.09	-0.05	-0.05	-0.02	-1.13
Debt / FCF Ratio	-0.10	-0.13	-0.05	-0.05	-0.02	-1.74
Quick Ratio	44.00	13.34	44.24	83.64	8.32	0.02
Current Ratio	44.84	13.81	45.13	84.09	8.22	0.03
Interest Coverage	-	-	-	-	-	-4064.00
Return on Equity (ROE)	-28.60%	-30.30%	-20.20%	-18.30%	101.60%	-
Return on Assets (ROA)	-27.00%	-28.50%	-19.60%	-16.30%	-112.90%	-
Return on Capital (ROIC)	-22.18%	-37.93%	-22.62%	-8.68%	68.89%	1915.34%
Earnings Yield	-8.61%	-11.59%	-17.25%	-4.53%	-	-
FCF Yield	-7.21%	-8.54%	-15.85%	-4.20%	-	-
Buyback Yield / Dilution	-23.20%	-1.96%	-203.94%	-793.58%	-51.14%	-
Total Shareholder Return	-23.20%	-1.96%	-203.94%	-793.58%	-51.14%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).